SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kolo55 who wrote (3983)8/8/2000 11:43:16 AM
From: Bridge Player  Read Replies (2) of 4140
 
<<Lehman expected $30M in revenues this year, and $80M next year... I think Sunrise will blow both numbers away. And since enough of the revenues will be coming from the $200 per eye royalty, a lot of the money will go to the bottom line. A year from now, it wouldn't surprise me to see this company on target to earn over a dollar per share for 2001>>

Hmmm...There are around 47 million shares outstanding. At $1/share earnings (I presume you mean after-tax, bottom line earnings), thats 47 million earnings. On 100 million in revenues, 47% net after tax. On 120 million, 40% net after tax.

Just wondering what your actual expectations are for 2001 sales, profit margins, and earnings?

BP
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext